David Stefanich

David Stefanich has held various positions in the industry since 2004. David began their career as CIO of Accuride Corporation in 2004. In 2009, they were appointed VP Strategic Delivery (IT) & Global Design Solutions (Integrated Prod Dev) at Navistar. David then moved to Michelin in 2012, where they served as Director of Technical Service Development - PLNA. From 2014 to 2017, they were the Managing Partner of Bridge Business Consortium. In 2018, they became a Founding Member of Blockchain in Healthcare Global (BiHG) - IEEE ISTO. David also Co-Founded and served as CEO of Rymedi in 2017. In 2021, they were appointed Member of the Industry Advisory Board at Clemson University and Chairman of the Board of Directors at SCBIO South Carolina Biotechnology Industry Organization.

David Stefanich holds a Master of Business Administration (MBA) from Mercer University's Stetson School of Business and Economics with a focus in International Business (Hong Kong). David also holds a Master of Computer Applications (MCA) from Mercer University with a focus in Computer Software Engineering. Additionally, they have attended Clemson University's Clemson Executive Summit and holds an M.S. in Chemistry from The University of Toledo.